Skip to main content
EPZM logo

Epizyme, Inc. (EPZM) Stock Analysis

DELISTED

What happened to Epizyme, Inc. (EPZM) stock?

Epizyme, Inc. (EPZM) no longer trades on public markets. The figures below are historical and are not a current quote.

Status:
Delisted — no longer trades
52-wk range: $1.47 – $1.50
Data from FMP · Methodology

For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Epizyme, Inc. (EPZM). Epizyme, Inc. is a commercial-stage biopharmaceutical company focused on developing novel epigenetic medicines for cancer and other diseases.

Last analyzed: Jun 14, 2026
Epizyme, Inc. is a commercial-stage biopharmaceutical company focused on developing novel epigenetic medicines for cancer and other diseases. As a subsidiary of Ipsen Biopharmaceuticals since 2022, it leverages its lead product, Tazemetostat, alongside a pipeline targeting various oncology indications and solid tumors.

Epizyme, Inc. (EPZM) Healthcare & Pipeline Overview

Employees250
Model self-rating on this text: 68% (not a measure of the evidence) Updated: Jun 14, 2026

More about this archive record

Can I still buy EPZM shares?

No. EPZM stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for EPZM elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before EPZM stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to Epizyme, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. Last updated: .

Data provided for informational purposes only.